{"brief_title": "A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients", "brief_summary": "This 6 month long study will assess an investigational medication for patients on dialysis with secondary hyperparathyroidism. The study will look at the effects on parathyroid hormone, calcium and phosphorus levels.", "condition": "End Stage Renal Disease", "intervention_type": "Drug", "intervention_name": "Placebo", "description": "30 mg QD orally 60 mg QD orally 90 mg QD orally 120 mg QD orally 180 mg QD orally", "arm_group_label": "placebo", "criteria": "- Patients must be receiving hemodialysis; * Have elevated parathyroid hormone levels; * Not be pregnant or nursing; and * Not have had a heart attack in the last 3 months.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00037635.xml"}